IP Library Patent Application 12503481
Patent Application
App. No. 12/503,481

GAS DISPENSER WITH THERAPEUTIC AGENT

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/503,481
Abstract

Various embodiments described herein promote accelerated healing of a wound. For example, in some embodiments, a gas emitter, such as an oxygen emitter, and a therapeutic agent, such as a zeolite, are positioned proximal to a wound. In some embodiments, the therapeutic agent is dispersed or contained in a substrate or pouch removably attached to the gas emitter. The therapeutic agent can be a topical agent configured to make contact with the wound during therapy.

Claims (25)

1 . A device for treating a wound, the device comprising:

a gas permeable pad configured to be placed in proximity to a wound, the gas permeable pad comprising a therapeutic agent; and

a gas dispenser disposed adjacent to the gas permeable pad, the gas dispenser configured to direct a gas through the gas permeable pad toward the wound.

2 . The device of claim 1 , wherein the gas dispenser is configured to direct a therapeutic concentration of oxygen through the gas permeable pad.

3 . The device of claim 1 , wherein the gas permeable pad comprises a material that is permeable to the gas.

4 . The device of claim 1 , wherein the gas permeable pad comprises a plurality of holes extending therethrough to allow the gas to pass through the gas permeable pad.

5 . The device of claim 1 , wherein the therapeutic agent is a molecular sieve material.

6 . The device of claim 5 , wherein the therapeutic agent comprises zeolite particles.

7 . The device of claim 6 , wherein the zeolite particles are granular zeolite particles.

8 . The device of claim 6 , wherein the zeolite particles have an average size greater than or equal to about 0.4 mm and less than or equal to about 2.4 mm.

9 . The device of claim 6 , wherein the zeolite particles have an average moisture content between about 5% and 15% by weight.

10 . The device of claim 1 , wherein the therapeutic agent is applied to a surface of the gas permeable pad configured to face the wound.

11 . The device of claim 1 , wherein the gas dispenser comprises an inlet configured to connect to an external gas supply.

12 . The device of claim 11 , wherein the gas dispenser comprises a plurality of outlets and one or more distribution structures contained within the gas dispenser, the distribution structures configured to affect the distribution of the gas through the outlets.

13 . The device of claim 2 , wherein the gas dispenser comprises an inlet for taking in atmospheric air and an oxygen generator contained within the gas dispenser, the oxygen generator configured to extract the oxygen from the atmospheric air and direct the oxygen toward the gas permeable pad.

14 . The device of claim 1 , wherein the gas permeable pad is removably attachable to the gas dispenser.

15 . The device of claim 1 , wherein the gas permeable pad is secured to the gas dispenser and the device is a single-use disposable unit.

16 . The device of claim 1 , wherein the gas dispenser comprises a flexible material and the gas dispenser also comprises one or more support structures disposed inside the gas dispenser, the support structures configured to prevent the gas dispenser from collapsing when pressure is applied to the gas dispenser.

17 . A method of treating a wound on a patient, comprising:

applying a gas permeable pad to the wound, the gas permeable pad comprising a therapeutic agent, such that the therapeutic agent is configured to be placed in direct contact with the wound; and

dispersing a gas through the gas permeable pad and onto the wound.

18 . The method of claim 17 , wherein the gas comprises a therapeutic concentration of oxygen.

19 . The method of claim 17 , wherein the wound is a non-bleeding wound.

20 . The method of claim 17 , wherein the therapeutic agent comprises zeolite particles.

21 . The method of claim 17 , wherein applying a gas permeable pad to the wound comprises placing the gas permeable pad directly under the patient such that the weight of the patient presses the therapeutic agent onto the wound.

Assignments (8)
CHANGE OF NAME Recorded Feb 29, 2024
From: TELEFLEX TECHNOLOGIES LLC
To: TELEFLEX LIFE SCIENCES II LLC
Reel/Frame 066836/0737 →
MERGER Recorded Feb 29, 2024
From: TELEFLEX LIFE SCIENCES II LLC
To: TELEFLEX TECHNOLOGIES LLC
Reel/Frame 066707/0695 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: TELEFLEX LIFE SCIENCES LIMITED
To: TELEFLEX LIFE SCIENCES II LLC
Reel/Frame 066434/0248 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2022
From: Z-MEDICA, LLC
To: TELEFLEX LIFE SCIENCES LIMITED
Reel/Frame 058740/0387 →
RELEASE AND REASSIGNMENT Recorded Apr 9, 2015
From: ABACUS FINANCE GROUP, LLC
To: Z-MEDICA, LLC
Reel/Frame 035389/0800 →
SECURITY AGREEMENT Recorded Sep 6, 2012
From: Z-MEDICA, LLC
To: ABACUS FINANCE GROUP, LLC
Reel/Frame 028917/0898 →
MERGER Recorded Sep 4, 2012
From: Z-MEDICA CORPORATION
To: Z-MEDICA, LLC
Reel/Frame 028896/0108 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2009
From: HURSEY, FRANCIS X.
To: Z-MEDICA CORPORATION
Reel/Frame 023257/0598 →